CB 1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity

Neuropsychopharmacology

Volumn 43, Issue 1, 2018, Pages 4-20

  Busquets Garcia, Arnau ^a,b   Bains, Jaideep ^c   Marsicano, Giovanni ^a,b  

^a INSTITUT FRANÇOIS MAGENDIE   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; GUANINE NUCLEOTIDE BINDING PROTEIN;

ALLOSTERIC SITE; BEHAVIOR; BRAIN; BRAIN FUNCTION; BRAIN MITOCHONDRION; CELL FUNCTION; CELL MEMBRANE; CELL SPECIFICITY; CELLULAR DISTRIBUTION; HUMAN; MACROGLIA; MEMORY; NERVE CELL; NEUROMODULATION; NONHUMAN; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE; SYNAPTOGENESIS; UBIQUITINATION; ANIMAL; METABOLISM;

ANIMALS; BRAIN; ENDOCANNABINOIDS; HUMANS; RECEPTOR, CANNABINOID, CB1; SYNAPSES;

EID: 85036650470     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2017.206     Document Type: Review

References (183)

1. Accardi MV, Daniels BA, Brown PM, Fritschy JM, Tyagarajan SK, Bowie D (2014). Mitochondrial reactive oxygen species regulate the strength of inhibitory GABAmediated synaptic transmission. Nat Commun 5: 3168.
2. Ahn KH, Mahmoud MM, Shim JY, Kendall DA (2013). Distinct roles of beta-arrestin 1 and beta-arrestin 2 in ORG27569-induced biased signaling and internalization of the cannabinoid receptor 1 (CB1). J Biol Chem 288: 9790-9800.
3. Aquila S, Guido C, Santoro A, Perrotta I, Laezza C, Bifulco M, et al (2010). Human sperm anatomy: Ultrastructural localization of the cannabinoid1 receptor and a potential role of anandamide in sperm survival and acrosome reaction. Anat Rec (Hoboken) 293: 298-309.
4. Araque A, Carmignoto G, Haydon PG, Oliet SH, Robitaille R, Volterra A (2014). Gliotransmitters travel in time and space. Neuron 81: 728-739.
5. Araque A, Castillo PE, Manzoni OJ, Tonini R (2017). Synaptic functions of endocannabinoid signaling in health and disease. Neuropharmacology 124: 13-24.
6. Bacci A, Huguenard JR, Prince DA (2004). Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature 431: 312-316.
7. Bagher AM, Laprairie RB, Kelly ME, Denovan-Wright EM (2013). Co-expression of the human cannabinoid receptor coding region splice variants (hCB(1)) affects the function of hCB(1) receptor complexes. Eur J Pharmacol 721: 341-354.
8. Bagher AM, Laprairie RB, Kelly ME, Denovan-Wright EM (2016). Antagonism of dopamine receptor 2 long affects cannabinoid receptor 1 signaling in a cell culture model of striatal medium spiny projection neurons. Mol Pharmacol 89: 652-666.
9. Bartova A, Birmingham MK (1976). Effect of delta9-tetrahydrocannabinol on mitochondrial NADH-oxidase activity. J Biol Chem 251: 5002-5006.
10. Bauer M, Chicca A, Tamborrini M, Eisen D, Lerner R, Lutz B, et al (2012). Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors. J Biol Chem 287: 36944-36967.
11. Bellocchio L, Lafenetre P, Cannich A, Cota D, Puente N, Grandes P, et al (2010). Bimodal control of stimulated food intake by the endocannabinoid system. Nat Neurosci 13: 281-283.
12. Benard G, Massa F, Puente N, Lourenco J, Bellocchio L, Soria-Gomez E, et al (2012). Mitochondrial CB(1) receptors regulate neuronal energy metabolism. Nat Neurosci 15: 558-564.
13. Bino T, Chari-Bitron A, Shahar A (1972). Biochemical effects and morphological changes in rat liver mitochondria exposed to 1-tetrahydrocannabinol. Biochim Biophys Acta 288: 195-202.
14. Blankman JL, Simon GM, Cravatt BF (2007). A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol 14: 1347-1356.
15. Bloomfield MA, Ashok AH, Volkow ND, Howes OD (2016). The effects of Delta9-tetrahydrocannabinol on the dopamine system. Nature 539: 369-377.
16. Blume LC, Patten T, Eldeeb K, Leone-Kabler S, Ilyasov AA, Keegan BM, et al (2017). Cannabinoid receptor interacting protein 1a competition with beta-arrestin for CB1 receptor binding sites. Mol Pharmacol 91: 75-86.
17. Bosier B, Bellocchio L, Metna-Laurent M, Soria-Gomez E, Matias I, Hebert-Chatelain E, et al (2013). Astroglial CB1 cannabinoid receptors regulate leptin signaling in mouse brain astrocytes. Mol Metab 2: 393-404.
18. Breivogel CS, Sim LJ, Childers SR (1997). Regional differences in cannabinoid receptor/G-protein coupling in rat brain. J Pharmacol Exp Ther 282: 1632-1642.
19. Brini M, Cali T, Ottolini D, Carafoli E (2014). Neuronal calcium signaling: Function and dysfunction. Cell Mol Life Sci 71: 2787-2814.
20. Buck J, Sinclair ML, Schapal L, Cann MJ, Levin LR (1999). Cytosolic adenylyl cyclase defines a unique signaling molecule in mammals. Proc Natl Acad Sci USA 96: 79-84.
21. Busquets-Garcia A, Desprez T, Metna-Laurent M, Bellocchio L, Marsicano G, Soria-Gomez E (2015). Dissecting the cannabinergic control of behavior: The where matters. BioEssays 37: 1215-1225.
22. Busquets-Garcia A, Gomis-Gonzalez M, Guegan T, Agustin-Pavon C, Pastor A, Mato S, et al (2013). Targeting the endocannabinoid system in the treatment of fragile X syndrome. Nat Med 19: 603-607.
23. Busquets-Garcia A, Gomis-Gonzalez M, Srivastava RK, Cutando L, Ortega-Alvaro A, Ruehle S, et al (2016). Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation. Proc Natl Acad Sci USA 113: 9904-9909.
24. Busquets-Garcia A, Soria-Gomez E, Redon B, Mackenbach Y, Vallee M, Chaouloff F, et al (2017). Pregnenolone blocks cannabinoid-induced acute psychotic-like states in mice. Mol Psychiatry. (e-pub ahead of print; doi:10.1038/mp.2017.4).
25. Caballero-Floran RN, Conde-Rojas I, Oviedo Chavez A, Cortes-Calleja H, Lopez-Santiago LF, Isom LL, et al (2016). Cannabinoid-induced depression of synaptic transmission is switched to stimulation when dopaminergic tone is increased in the globus pallidus of the rodent. Neuropharmacology 110(Pt A): 407-418.
26. Callen L, Moreno E, Barroso-Chinea P, Moreno-Delgado D, Cortes A, Mallol J, et al (2012). Cannabinoid receptors CB1 and CB2 form functional heteromers in brain. J Biol Chem 287: 20851-20865.
27. Campbell VA (2001). Tetrahydrocannabinol-induced apoptosis of cultured cortical neurones is associated with cytochrome c release and caspase-3 activation. Neuropharmacology 40: 702-709.
28. Castillo PE, Younts TJ, Chavez AE, Hashimotodani Y (2012). Endocannabinoid signaling and synaptic function. Neuron 76: 70-81.
29. Chari-Bitron A, Bino T (1971). Effect of 1-tetrahydrocannabinol on ATPase activity of rat liver mitochondria. Biochem Pharmacol 20: 473-475.
30. Chávez AE, Chiu CQ, Castillo PE (2010). TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus. Nat Neurosci 13: 1511-1518.
31. Chen K, Neu A, Howard AL, Foldy C, Echegoyen J, Hilgenberg L, et al (2007). Prevention of plasticity of endocannabinoid signaling inhibits persistent limbic hyperexcitability caused by developmental seizures. J Neurosci 27: 46-58.
32. Chen K, Ratzliff A, Hilgenberg L, Gulyas A, Freund TF, Smith M, et al (2003). Longterm plasticity of endocannabinoid signaling induced by developmental febrile seizures. Neuron 39: 599-611.
33. Chen Y, Cann MJ, Litvin TN, Iourgenko V, Sinclair ML, Levin LR, et al (2000). Soluble adenylyl cyclase as an evolutionarily conserved bicarbonate sensor. Science 289: 625-628.
34. Cheng A, Hou Y, Mattson MP (2010). Mitochondria and neuroplasticity. ASN Neuro 2: E00045.
35. Costa-Mattioli M, Monteggia LM (2013). mTOR complexes in neurodevelopmental and neuropsychiatric disorders. Nat Neurosci 16: 1537-1543.
36. Delgado-Peraza F, Ahn KH, Nogueras-Ortiz C, Mungrue IN, Mackie K, Kendall DA, et al (2016). Mechanisms of biased beta-arrestin-mediated signaling downstream from the cannabinoid 1 receptor. Mol Pharmacol 89: 618-629.
37. Derkinderen P, Toutant M, Burgaya F, Le Bert M, Siciliano JC, de Franciscis V, et al (1996). Regulation of a neuronal form of focal adhesion kinase by anandamide. Science 273: 1719-1722.
38. Derkinderen P, Valjent E, Toutant M, Corvol JC, Enslen H, Ledent C, et al (2003). Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. J Neurosci 23: 2371-2382.
39. Di Marzo V, De Petrocellis L, Fezza F, Ligresti A, Bisogno T (2002). Anandamide receptors. Prostaglandins Leukot Essent Fatty Acids 66: 377-391.
40. Diez-Alarcia R, Ibarra-Lecue I, Lopez-Cardona AP, Meana J, Gutierrez-Adan A, Callado LF, et al (2016). Biased agonism of three different cannabinoid receptor agonists in mouse brain cortex. Front Pharmacol 7: 415.
41. Dubreucq S, Matias I, Cardinal P, Haring M, Lutz B, Marsicano G, et al (2012). Genetic dissection of the role of cannabinoid type-1 receptors in the emotional consequences of repeated social stress in mice. Neuropsychopharmacology 37: 1885-1900.
42. Fernandez-Ruiz J, Pazos MR, Garcia-Arencibia M, Sagredo O, Ramos JA (2008). Role of CB2 receptors in neuroprotective effects of cannabinoids. Mol Cell Endocrinol 286(1-2 Suppl 1): S91-S96.
43. Foldy C, Neu A, Jones MV, Soltesz I (2006). Presynaptic, activity-dependent modulation of cannabinoid type 1 receptor-mediated inhibition of GABA release. J Neurosci 26: 1465-1469.
44. Forss DA (1972). Odor and flavor compounds from lipids. Prog Chem Fats Other Lipids 13: 177-258.
45. Freund TF, Katona I, Piomelli D (2003). Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83: 1017-1066.
46. Gantz SC, Bean BP (2017). Cell-autonomous excitation of midbrain dopamine neurons by endocannabinoid-dependent lipid signaling. Neuron 93: 1375-1387 e1372.
47. Gentles AJ, Karlin S (1999). Why are human G-protein-coupled receptors predominantly intronless Trends Genet 15: 47-49.
48. Glass M, Felder CC (1997). Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: Evidence for a Gs linkage to the CB1 receptor. J Neurosci 17: 5327-5333.
49. Gomez-Gonzalo M, Navarrete M, Perea G, Covelo A, Martin-Fernandez M, Shigemoto R, et al (2015). Endocannabinoids induce lateral long-term potentiation of transmitter release by stimulation of gliotransmission. Cereb Cortex 25: 3699-3712.
50. Guggenhuber S, Alpar A, Chen R, Schmitz N, Wickert M, Mattheus T, et al (2016). Cannabinoid receptor-interacting protein Crip1a modulates CB1 receptor signaling in mouse hippocampus. Brain Struct Funct 221: 2061-2074.
51. Gulyas AI, Cravatt BF, Bracey MH, Dinh TP, Piomelli D, Boscia F, et al (2004). Segregation of two endocannabinoid-hydrolyzing enzymes into pre-A nd postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur J Neurosci 20: 441-458.
52. Halassa MM, Haydon PG (2010). Integrated brain circuits: Astrocytic networks modulate neuronal activity and behavior. Annu Rev Physiol 72: 335-355.
53. Han J, Kesner P, Metna-Laurent M, Duan T, Xu L, Georges F, et al (2012). acute cannabinoids impair working memory through astroglial CB(1) receptor modulation of hippocampal LTD. Cell 148: 1039-1050.
54. Hao S, Avraham Y, Mechoulam R, Berry EM (2000). Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in dietrestricted mice. Eur J Pharmacol 392: 147-156.
55. Haring M, Enk V, Aparisi Rey A, Loch S, Ruiz de Azua I, Weber T, et al (2015). Cannabinoid type-1 receptor signaling in central serotonergic neurons regulates anxiety-like behavior and sociability. Front Behav Neurosci 9: 235.
56. Harkany T, Horvath TL (2017). (S)Pot on mitochondria: Cannabinoids disrupt cellular respiration to limit neuronal activity. Cell Metab 25: 8-10.
57. Hebert-Chatelain E, Desprez T, Serrat R, Bellocchio L, Soria-Gomez E, Busquets-Garcia A, et al (2016). A cannabinoid link between mitochondria and memory. Nature 539: 555-559.
58. Hebert-Chatelain E, Reguero L, Puente N, Lutz B, Chaouloff F, Rossignol R, et al (2014). Cannabinoid control of brain bioenergetics: Exploring the subcellular localization of the CB1 receptor. Mol Metab 3: 495-504.
59. Heifets BD, Chevaleyre V, Castillo PE (2008). Interneuron activity controls endocannabinoid-mediated presynaptic plasticity through calcineurin. Proc Natl Acad Sci USA 105: 10250-10255.
60. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, et al (1990). Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87: 1932-1936.
61. Hermann H, Marsicano G, Lutz B (2002). Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. Neuroscience 109: 451-460.
62. Hofer SC, Ralvenius WT, Gachet MS, Fritschy JM, Zeilhofer HU, Gertsch J (2015). Localization and production of peptide endocannabinoids in the rodent CNS and adrenal medulla. Neuropharmacology 98: 78-89.
63. Hojo M, Sudo Y, Ando Y, Minami K, Takada M, Matsubara T, et al (2008). mu-Opioid receptor forms a functional heterodimer with cannabinoid CB1 receptor: Electrophysiological and FRET assay analysis. J Pharmacol Sci 108: 308-319.
64. Howlett AC (1984). Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds. Life Sci 35: 1803-1810.
65. Howlett AC (1987). Cannabinoid inhibition of adenylate cyclase: Relative activity of constituents and metabolites of marihuana. Neuropharmacology 26: 507-512.
66. Howlett AC (2005). Cannabinoid receptor signaling. Handb Exp Pharmacol 168: 53-79.
67. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, et al (2002). International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54: 161-202.
68. Howlett AC, Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Porrino LJ (2004). Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 47(Suppl 1): 345-358.
69. Hua T, Vemuri K, Pu M, Qu L, Han GW, Wu Y, et al (2016). Crystal structure of the human cannabinoid receptor CB1. Cell 167: 750-762 e714.
70. Hua T, Vemuri K, Nikas SP, Laprairie RB, Wu Y, Qu L, et al (2017). Crystal structures of agonist-bound human cannabinoid receptor CB(1). Nature 547: 468-471.
71. Hudson BD, Hebert TE, Kelly ME (2010). Ligand-A nd heterodimer-directed signaling of the CB(1) cannabinoid receptor. Mol Pharmacol 77: 1-9.
72. Hurst DP, Grossfield A, Lynch DL, Feller S, Romo TD, Gawrisch K, et al (2010). A lipid pathway for ligand binding is necessary for a cannabinoid G protein-coupled receptor. J Biol Chem 285: 17954-17964.
73. Hurst DP, Schmeisser M, Reggio PH (2013). Endogenous lipid activated G proteincoupled receptors: Emerging structural features from crystallography and molecular dynamics simulations. Chem Phys Lipids 169: 46-56.
74. Inda C, Dos Santos Claro PA, Bonfiglio JJ, Senin SA, Maccarrone G, Turck CW, et al (2016). Different cAMP sources are critically involved in G protein-coupled receptor CRHR1 signaling. J Cell Biol 214: 181-195.
75. Irannejad R, Pessino V, Mika D, Huang B, Wedegaertner PB, Conti M, et al (2017). Functional selectivity of GPCR-directed drug action through location bias. Nat Chem Biol 13: 799-806.
76. Irannejad R, Tomshine JC, Tomshine JR, Chevalier M, Mahoney JP, Steyaert J, et al (2013). Conformational biosensors reveal GPCR signalling from endosomes. Nature 495: 534-538.
77. Jalink K, Moolenaar WH (2010). G protein-coupled receptors: The inside story. Bioessays 32: 13-16.
78. Jong YJ, Sergin I, Purgert CA, O'Malley KL (2014). Location-dependent signaling of the group 1 metabotropic glutamate receptor mGlu5. Mol Pharmacol 86: 774-785.
79. Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M (2009). Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 89: 309-380.
80. Katona I, Freund TF (2008). Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat Med 14: 923-930.
81. Katona I, Freund TF (2012). Multiple functions of endocannabinoid signaling in the brain. Annu Rev Neurosci 35: 529-558.
82. Katona I, Urban GM, Wallace M, Ledent C, Jung KM, Piomelli D, et al (2006). Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci 26: 5628-5637.
83. Kearn CS, Blake-Palmer K, Daniel E, Mackie K, Glass M (2005). Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: A mechanism for receptor cross-talk Mol Pharmacol 67: 1697-1704.
84. Khajehali E, Malone DT, Glass M, Sexton PM, Christopoulos A, Leach K (2015). Biased agonism and biased allosteric modulation at the CB1 cannabinoid receptor. Mol Pharmacol 88: 368-379.
85. Khan SS, Lee FJ (2014). Delineation of domains within the cannabinoid CB1 and dopamine D2 receptors that mediate the formation of the heterodimer complex. J Mol Neurosci 53: 10-21.
86. Khan SM, Sung JY, Hébert TE (2016). G subunits-different spaces, different faces. Pharmacol Res 111: 434-441.
87. Kimura T, Cheng K, Rice KC, Gawrisch K (2009). Location, structure, and dynamics of the synthetic cannabinoid ligand CP-55, 940 in lipid bilayers. Biophys J 96: 4916-4924.
88. Koch M, Varela L, Kim JG, Kim JD, Hernandez-Nuno F, Simonds SE, et al (2015). Hypothalamic POMC neurons promote cannabinoid-induced feeding. Nature 519: 45-50.
89. Kreitzer AC, Carter AG, Regehr WG (2002). Inhibition of interneuron firing extends the spread of endocannabinoid signaling in the cerebellum. Neuron 34: 787-796.
90. Krohmer A, Brehm M, Auwärter V, Szabo B (2017). Pregnenolone does not interfere with the effects of cannabinoids on synaptic transmission in the cerebellum and the nucleus accumbens. Pharmacol Res 123: 51-61.
91. Kuzmiski JB, Pittman QJ, Bains JS (2009). Metaplasticity of hypothalamic synapses following in vivo challenge. Neuron 62: 839-849.
92. Lafenetre P, Chaouloff F, Marsicano G (2009). Bidirectional regulation of noveltyinduced behavioral inhibition by the endocannabinoid system. Neuropharmacology 57: 715-721.
93. Laplante M, Sabatini DM (2012). mTOR Signaling. Cold Spring Harbor Perspect Biol 4: 2.
94. Lee SH, Ledri M, Toth B, Marchionni I, Henstridge CM, Dudok B, et al (2015). Multiple forms of endocannabinoid and endovanilloid signaling regulate the tonic control of GABA release. J Neurosci 35: 10039-10057.
95. Li Y, Kim J (2016). CB2 cannabinoid receptor knockout in mice impairs contextual long-term memory and enhances spatial working memory. Neural Plast 2016: 9817089.
96. Lourenco J, Cannich A, Carta M, Coussen F, Mulle C, Marsicano G (2010). Synaptic activation of kainate receptors gates presynaptic CB(1) signaling at GABAergic synapses. Nat Neurosci 13: 197-204.
97. Lu HC, Mackie K (2016). An introduction to the endogenous cannabinoid system. Biol Psychiatry 79: 516-525.
98. Mackie K, Hille B (1992). Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci USA 89: 3825-3829.
99. Mackie K (2005). Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb Exp Pharmacol 168: 299-325.
100. Mahoney JM, Harris RA (1972). Effect of 9-tetrahydrocannabinol on mitochondrial precesses. Biochem Pharmacol 21: 1217-1226.
101. Marinelli S, Pacioni S, Cannich A, Marsicano G, Bacci A (2009). Self-modulation of neocortical pyramidal neurons by endocannabinoids. Nat Neurosci 12: 1488-1490.
102. Maroso M, Szabo GG, Kim HK, Alexander A, Bui AD, Lee SH, et al (2016). Cannabinoid control of learning and memory through HCN channels. Neuron 89: 1059-1073.
103. Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, et al (2003). CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302: 84-88.
104. Marsicano G, Kuner R (2008). Anatomical distribution of receptors, ligands and enzymes in the brain and the spinal cord: Circuitries and neurochemistry In: Kofalvi A (ed) Cannabinoids and the Brain. Springer: New York, NY, USA. pp 161-202.
105. Martin R, Bajo-Graneras R, Moratalla R, Perea G, Araque A (2015). GLIAL CELL SIGNALING. Circuit-specific signaling in astrocyte-neuron networks in basal ganglia pathways. Science 349: 730-734.
106. Mato S, Alberdi E, Ledent C, Watanabe M, Matute C (2009). CB1 cannabinoid receptor-dependent and-independent inhibition of depolarization-induced calcium influx in oligodendrocytes. Glia 57: 295-306.
107. Mattson MP, Gleichmann M, Cheng A (2008). Mitochondria in neuroplasticity and neurological disorders. Neuron 60: 748-766.
108. Mendizabal-Zubiaga J, Melser S, Benard G, Ramos A, Reguero L, Arrabal S, et al (2016). Cannabinoid CB1 receptors are localized in striated muscle mitochondria and regulate mitochondrial respiration. Front Physiol 7: 476.
109. Metna-Laurent M, Marsicano G (2015). Rising stars: Modulation of brain functions by astroglial type-1 cannabinoid receptors. Glia 63: 353-364.
110. Metna-Laurent M, Soria-Gomez E, Verrier D, Conforzi M, Jego P, Lafenetre P, et al (2012). Bimodal control of fear-coping strategies by CB(1) cannabinoid receptors. J Neurosci 32: 7109-7118.
111. Miederer I, Uebbing K, Rohrich J, Maus S, Bausbacher N, Krauter K, et al (2017). Effects of tetrahydrocannabinol on glucose uptake in the rat brain. Neuropharmacology 117: 273-281.
112. Mikasova L, Groc L, Choquet D, Manzoni OJ (2008). Altered surface trafficking of presynaptic cannabinoid type 1 receptor in and out synaptic terminals parallels receptor desensitization. Proc Natl Acad Sci USA 105: 18596-18601.
113. Min R, Nevian T (2012). Astrocyte signaling controls spike timing-dependent depression at neocortical synapses. Nat Neurosci 15: 746-753.
114. Miraucourt LS, Tsui J, Gobert D, Desjardins JF, Schohl A, Sild M, et al (2016). Endocannabinoid signaling enhances visual responses through modulation of intracellular chloride levels in retinal ganglion cells. eLife 5: E15932.
115. Monory K, Massa F, Egertova M, Eder M, Blaudzun H, Westenbroek R, et al (2006). The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51: 455-466.
116. Moreno E, Chiarlone A, Medrano M, Puigdellivol M, Bibic L, Howell LA, et al (2017). Singular location and signaling profile of adenosine A2A-Cannabinoid CB1 receptor heteromers in the dorsal striatum. Neuropsychopharmacology (e-pub ahead of print; doi:10.1038/npp.2017.12).
117. Morré DJ, Mollenhauer HH (1974). The endomembrane concept: A functional integration of endoplasmic reticulum and Golgi apparatus. In: Robards AW (ed). Dynamic Aspects of Plant Infrastructure. McGraw-Hill: London, UK. pp 441-481.
118. Morozov YM, Ben-Ari Y, Freund TF (2004). The spatial and temporal pattern of fatty acid amide hydrolase expression in rat hippocampus during postnatal development. Eur J Neurosci 20: 459-466.
119. Navarrete M, Araque A (2008). Endocannabinoids mediate neuron-astrocyte communication. Neuron 57: 883-893.
120. Navarrete M, Araque A (2010). Endocannabinoids potentiate synaptic transmission through stimulation of astrocytes. Neuron 68: 113-126.
121. Navarro G, Morales P, Rodriguez-Cueto C, Fernandez-Ruiz J, Jagerovic N, Franco R (2016). Targeting cannabinoid CB2 receptors in the central nervous system. Medicinal chemistry approaches with focus on neurodegenerative disorders. Front Neurosci 10: 406.
122. Niehaus JL, Liu Y, Wallis KT, Egertova M, Bhartur SG, Mukhopadhyay S, et al (2007). CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP 1a. Mol Pharmacol 72: 1557-1566.
123. Nogueras-Ortiz C, Yudowski GA (2016). The multiple waves of cannabinoid 1 receptor signaling. Mol Pharmacol 90: 620-626.
124. Oddi S, Stepniewski TM, Totaro A, Selent J, Scipioni L, Dufrusine B, et al (2017). Palmitoylation of cysteine 415 of CB1 receptor affects ligand-stimulated internalization and selective interaction with membrane cholesterol and caveolin 1. Biochim Biophys Acta 1862: 523-532.
125. Oliet SH, Baimoukhametova DV, Piet R, Bains JS (2007). Retrograde regulation of GABA transmission by the tonic release of oxytocin and endocannabinoids governs postsynaptic firing. J Neurosci 27: 1325-1333.
126. Oliveira da Cruz JF, Robin LM, Drago F, Marsicano G, Metna-Laurent M (2016). Astroglial type-1 cannabinoid receptor (CB1): A new player in the tripartite synapse. Neuroscience 323: 35-42.
127. Omiya Y, Uchigashima M, Konno K, Yamasaki M, Miyazaki T, Yoshida T, et al (2015). VGluT3-expressing CCK-positive basket cells construct invaginating synapses enriched with endocannabinoid signaling proteins in particular cortical and cortexlike amygdaloid regions of mouse brains. J Neurosci 35: 4215-4228.
128. Onaivi ES, Chaudhuri G, Abaci AS, Parker M, Manier DH, Martin PR, et al (1999). Expression of cannabinoid receptors and their gene transcripts in human blood cells. Prog Neuropsychopharmacol Biol Psychiatry 23: 1063-1077.
129. Onaivi ES, Ishiguro H, Gu S, Liu QR (2012). CNS effects of CB2 cannabinoid receptors: Beyond neuro-immuno-cannabinoid activity. J Psychopharmacol 26: 92-103.
130. Ortega-Alvaro A, Aracil-Fernandez A, Garcia-Gutierrez MS, Navarrete F, Manzanares J (2011). Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice. Neuropsychopharmacology 36: 1489-1504.
131. Oz M, Ravindran A, Diaz-Ruiz O, Zhang L, Morales M (2003). The endogenous cannabinoid anandamide inhibits alpha7 nicotinic acetylcholine receptormediated responses in Xenopus oocytes. J Pharmacol Exp Ther 306: 1003-1010.
132. Pamplona FA, Ferreira J, Menezes de Lima O Jr, Duarte FS, Bento AF, Forner S, et al (2012). Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor. Proc Natl Acad Sci USA 109: 21134-21139.
133. Pelkey KA, Lavezzari G, Racca C, Roche KW, McBain CJ (2005). mGluR7 is a metaplastic switch controlling bidirectional plasticity of feedforward inhibition. Neuron 46: 89-102.
134. Perrey DA, Gilmour BP, Thomas BF, Zhang Y (2014). Toward the development of bivalent ligand probes of cannabinoid CB1 and Orexin OX1 receptor heterodimers. ACS Med Chem Lett 5: 634-638.
135. Piazza PV, Cota D, Marsicano G (2017). The CB1 receptor as the cornerstone of exostasis. Neuron 93: 1252-1274.
136. Piazza PV, Vallee M, Marsicano G, Felpin FX, Bellocchio L, Cota D, et al (2012). Antagonists of CB1 receptor. In: WIPO (ed). Available at https://www.google.fr/patents/US20140200200dq=piazza+marsicano&hl=en&sa=X&ved=0ahUKEwi d4oGi7s-WAhVCbVAKHWodB1cQ6AEIPjAC. Accessed 1 October 2017.
137. Picard M (2015). Mitochondrial synapses: Intracellular communication and signal integration. Trends Neurosci 38: 468-474.
138. Piomelli D (2003). The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4: 873-884.
139. Prather PL, Martin NA, Breivogel CS, Childers SR (2000). Activation of cannabinoid receptors in rat brain by WIN 55212-2 produces coupling to multiple G protein alpha-subunits with different potencies. Mol Pharmacol 57: 1000-1010.
140. Puente N, Cui Y, Lassalle O, Lafourcade M, Georges F, Venance L, et al (2011). Polymodal activation of the endocannabinoid system in the extended amygdala. Nat Neurosci 14: 1542-1547.
141. Puighermanal E, Marsicano G, Busquets-Garcia A, Lutz B, Maldonado R, Ozaita A (2009). Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nat Neurosci 12: 1152-1158.
142. Raefsky SM, Mattson MP (2017). Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance. Free Radic Biol Med 102: 203-216.
143. Raehal KM, Bohn LM (2014). Beta-arrestins: Regulatory role and therapeutic potential in opioid and cannabinoid receptor-mediated analgesia. Handb Exp Pharmacol 219: 427-443.
144. Rangaraju V, Calloway N, Ryan TA (2014). Activity-driven local ATP synthesis is required for synaptic function. Cell 156: 825-835.
145. Reggio PH (2010). Endocannabinoid binding to the cannabinoid receptors: What is known and what remains unknown. Curr Med Chem 17: 1468-1486.
146. Rey AA, Purrio M, Viveros MP, Lutz B (2012). Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission. Neuropsychopharmacology 37: 2624-2634.
147. Rozenfeld R, Devi LA (2008). Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3. FASEB J 22: 2311-2322.
148. Ruehle S, Wager-Miller J, Straiker A, Farnsworth J, Murphy MN, Loch S, et al (2017). Discovery and characterization of two novel CB1 receptor splice variants with modified N-termini in mouse. J Neurochem 142: 521-533.
149. Schurr A, Livne A (1975). Proceedings: Differential inhibition of mitochondrial monoamine oxidase from brain by hashish components. Israel J Med Sci 11: 1188.
150. Schweitzer P (2000). Cannabinoids decrease the K(+) M-current in hippocampal CA1 neurons. J Neurosci 20: 51-58.
151. Shao Z, Yin J, Chapman K, Grzemska M, Clark L, Wang J, et al (2016). Highresolution crystal structure of the human CB1 cannabinoid receptor. Nature (e-pub ahead of print; doi:10.1038/nature20613).
152. Sigel E, Baur R, Racz I, Marazzi J, Smart TG, Zimmer A, et al (2011). The major central endocannabinoid directly acts at GABA(A) receptors. Proc Natl Acad Sci USA 108: 18150-18155.
153. Smith TH, Blume LC, Straiker A, Cox JO, David BG, McVoy JR, et al (2015). Cannabinoid receptor-interacting protein 1a modulates CB1 receptor signaling and regulation. Mol Pharmacol 87: 747-765.
154. Smith TH, Sim-Selley LJ, Selley DE (2010). Cannabinoid CB1 receptor-interacting proteins: Novel targets for central nervous system drug discovery Br J Pharmacol 160: 454-466.
155. Soria-Gomez E, Busquets-Garcia A, Hu F, Mehidi A, Cannich A, Roux L, et al (2015). Habenular CB1 receptors control the expression of aversive memories. Neuron 88: 306-313.
156. Steegborn C (2014). Structure, mechanism, and regulation of soluble adenylyl cyclases-similarities and differences to transmembrane adenylyl cyclases. Biochim Biophys Acta 1842(12 Pt B): 2535-2547.
157. Steindel F, Lerner R, Haring M, Ruehle S, Marsicano G, Lutz B, et al (2013). Neurontype specific cannabinoid-mediated G protein signalling in mouse hippocampus. J Neurochem 124: 795-807.
158. Straiker A, Wager-Miller J, Hutchens J, Mackie K (2012). Differential signalling in human cannabinoid CB1 receptors and their splice variants in autaptic hippocampal neurones. Br J Pharmacol 165: 2660-2671.
159. Sultan S, Li L, Moss J, Petrelli F, Casse F, Gebara E, et al (2015). Synaptic integration of adult-born hippocampal neurons is locally controlled by astrocytes. Neuron 88: 957-972.
160. Suzuki A, Stern SA, Bozdagi O, Huntley GW, Walker RH, Magistretti PJ, et al (2011). Astrocyte-neuron lactate transport is required for long-term memory formation. Cell 144: 810-823.
161. Turu G, Hunyady L (2010). Signal transduction of the CB1 cannabinoid receptor. J1 Mol Endocrinol 44: 75-85.
162. Thibault K, Carrel D, Bonnard D, Gallatz K, Simon A, Biard M, et al (2013). Activationdependent subcellular distribution patterns of CB1 cannabinoid receptors in the rat forebrain. Cereb Cortex 23: 2581-2591.
163. Tsvetanova NG, Irannejad R, von Zastrow M (2015). G protein-coupled receptor (GPCR) signaling via heterotrimeric G proteins from endosomes. J Biol Chem 290: 6689-6696.
164. Twitchell W, Brown S, Mackie K (1997). Cannabinoids inhibit N-A nd P/Q-type calcium channels in cultured rat hippocampal neurons. J Neurophysiol 78: 43-50.
165. Vallee M, Vitiello S, Bellocchio L, Hebert-Chatelain E, Monlezun S, Martin-Garcia E, et al (2014). Pregnenolone can protect the brain from cannabis intoxication. Science 343: 94-98.
166. Vargish GA, McBain CJ (2016). The hyperpolarization-activated cation current Ih: The missing link connecting cannabinoids to cognition. Neuron 89: 889-891.
167. Vasquez C, Lewis DL (1999). The CB1 cannabinoid receptor can sequester G-proteins, making them unavailable to couple to other receptors. J Neurosci 19: 9271-9280.
168. Vinals X, Moreno E, Lanfumey L, Cordomi A, Pastor A, de La Torre R, et al (2015). Cognitive impairment induced by delta9-tetrahydrocannabinol occurs through heteromers between cannabinoid CB1 and serotonin 5-HT2A receptors. PLoS Biol 13: E1002194.
169. Voelker DR (1991). Organelle biogenesis and intracellular lipid transport in eukaryotes. Microbiol Rev 55: 543-560.
170. Wager-Miller J, Westenbroek R, Mackie K (2002). Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example. Chem Phys Lipids 121: 83-89.
171. Wamsteeker Cusulin JI, Senst L, Teskey GC, Bains JS (2014). Experience salience gates endocannabinoid signaling at hypothalamic synapses. J Neurosci 34: 6177-6181.
172. Wamsteeker JI, Bains JS (2010a). A synaptocentric view of the neuroendocrine response to stress. Eur J Neurosci 32: 2011-2021.
173. Wamsteeker JI, Kuzmiski JB, Bains JS (2010b). Repeated stress impairs endocannabinoid signaling in the paraventricular nucleus of the hypothalamus. J Neurosci 30: 11188-11196.
174. Wittmann G, Deli L, Kallo I, Hrabovszky E, Watanabe M, Liposits Z, et al (2007). Distribution of type 1 cannabinoid receptor (CB1)-immunoreactive axons in the mouse hypothalamus. J Comp Neurol 503: 270-279.
175. www.nobelprize.org (2014). The Nobel Prize in Chemistry 2012-Advanced Information. https://www.nobelprize.org/nobel-prizes/chemistry/laureates/2012/.
176. Xiong W, Wu X, Li F, Cheng K, Rice KC, Lovinger DM, et al (2012). A common molecular basis for exogenous and endogenous cannabinoid potentiation of glycine receptors. J Neurosci 32: 5200-5208.
177. Yao B, Mackie K (2009). Endocannabinoid receptor pharmacology. Curr Top Behav Neurosci 1: 37-63.
178. Yoshida T, Uchigashima M, Yamasaki M, Katona I, Yamazaki M, Sakimura K, et al (2011). Unique inhibitory synapse with particularly rich endocannabinoid signaling machinery on pyramidal neurons in basal amygdaloid nucleus. Proc Natl Acad Sci USA 108: 3059-3064.
179. Younts TJ, Chevaleyre V, Castillo PE (2013). CA1 pyramidal cell theta-burst firing triggers endocannabinoid-mediated long-term depression at both somatic and dendritic inhibitory synapses. J Neurosci 33: 13743-13757.
180. Younts TJ, Monday HR, Dudok B, Klein ME, Jordan BA, Katona I, et al (2016). Presynaptic protein synthesis is required for long-term plasticity of GABA release. Neuron 92: 479-492.
181. Zhu PJ, Lovinger DM (2007). Persistent synaptic activity produces long-lasting enhancement of endocannabinoid modulation and alters long-term synaptic plasticity. J Neurophysiol 97: 4386-4389.
182. Zhuang S, Hampson RE, Deadwyler SA (2005). Behaviorally relevant endocannabinoid action in hippocampus: Dependence on temporal summation of multiple inputs. Behav Pharmacol 16: 463-471.
183. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sørgård M, Di Marzo V, et al (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400: 452-457.